1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel

Diagnostics guidance [DG11] Published: 02 October 2013

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
  • Overview
  • 1 Recommendations
  • 2 The technologies
  • 3 Clinical need and practice
  • 4 The diagnostic tests
  • 5 Outcomes
  • 6 Considerations
  • 7 Recommendations for further research
  • 8 Implementation
  • 9 Related NICE guidance
  • 10 Review
  • 11 Diagnostics Advisory Committee members and NICE project team
  • 12 Sources of evidence considered by the Committee
Download guidance (PDF)

Guidance

  • Next

9 Related NICE guidance

9 Related NICE guidance

  • Ulcerative colitis: management in adults, children and young people. NICE clinical guideline 166 (2013).

  • Crohn's disease: management in adults, children and young people. NICE clinical guideline 152 (2012).

  • Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas. NICE clinical guideline 118 (2011).

  • Infliximab (review) and adalimumab for the treatment of Crohn's disease. NICE technology appraisal 187 (2010).

  • Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. NICE clinical guideline 61 (2008).

  • Infliximab for acute exacerbations of ulcerative colitis. NICE technology appraisal 163 (2008).

  • Infliximab for subacute manifestations of ulcerative colitis. NICE technology appraisal 140 (2008).


  • Next